SCHEMBL17657298

SCHEMBL17657298

C=Cc1cccc2oc(CC)c(Br)c(=O)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 5/20 0.36
▸ CYP2C9 P11712 6/20 0.36
▸ ESR2 Q92731 1/20 0.35
▸ GABRA1 P14867 1/20 0.33
▸ GABRB2 P47870 1/20 0.33
▸ CYP2C19 P33261 4/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ SLC22A12 Q96S37 2/20 0.33
▸ EYA3 Q99504 2/20 0.33
▸ EYA2 O00167 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ABCC4 O15439 1/20 0.33
▸ PLIN1 O60240 1/20 0.33
▸ NR1I2 O75469 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ ABCB11 O95342 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ ALB P02768 1/20 0.33
▸ ESR1 P03372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17657299 0.80 MAPT (0.36) TTRCYP2C9ESR2CYP2C19CYP3A4
SCHEMBL17718329 0.78 TTR (0.47) TTRCYP2C9GABRA1GABRB2CYP2C19
SCHEMBL13717661 0.78 TTR (0.39) TTRCYP2C9GABRA1GABRB2CYP2C19
SCHEMBL17657317 0.71 HTR2B (0.40) ESR2PPARGHTR2B
SCHEMBL16952751 0.68 GABRA1 (0.61) GABRA1GABRB2MEN1ALDH1A1LMNA
SCHEMBL13718295 0.67 CYP2C9 (0.38) TTRCYP2C9GABRA1GABRB2
SCHEMBL4518061 0.66 GABRA1 (0.39) ESR2GABRA1GABRB2CYP3A4ALDH1A1
SCHEMBL2775764 0.64 CYP2C19 (0.50) TTRCYP2C9CYP2C19CYP3A4SLC22A12
SCHEMBL17657308 0.64 MEN1 (0.34) ESR2CYP3A4MEN1USP2ALDH1A1
SCHEMBL9078888 0.63 CYP3A4 (0.67) CYP2C9CYP2C19CYP3A4MEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016054491-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2016-04-07 — — WO disclosed
Send feedback